Basic information Safety Supplier Related

4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime

Basic information Safety Supplier Related

4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime Basic information

Product Name:
4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime
Synonyms:
  • AP-18
  • 4-(4-Chlorophenyl)-3-methyl-3-buten-2-oneoxime
  • 4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime
  • 4-(4-Chlorophenyl)-3-methylbut-3-en-2-one oxime
  • 3-Buten-2-one, 4-(4-chlorophenyl)-3-methyl-, oxime
  • ganglia,TRP Channel,nerves,pain,AP18,Transient receptor potential channels,AP-18,AP 18,inhibit,nociceptive,root,hyperalgesia,Inhibitor,transduction,dorsal
CAS:
55224-94-7
MF:
C11H12ClNO
MW:
209.67
Product Categories:
  • Aromatics, Pharmaceuticals, Intermediates & Fine Chemicals
Mol File:
55224-94-7.mol
More
Less

4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime Chemical Properties

storage temp. 
2-8°C
solubility 
DMSO: >10mg/mL
form 
solid
color 
white to off-white
Stability:
Stable for 2 years from date of purchase as supplied. Solutions in DMSO or ethanol may be stored at -20°C for up to 2 months.
More
Less

Safety Information

Hazard Codes 
Xn
Risk Statements 
22
WGK Germany 
3
More
Less

4-(4-Chlorophenyl)-3-methylbut-3-en-2-oxime Usage And Synthesis

Description

AP-18 is a channel blocker which reversibly inhibits TRPA1 (IC50s = 3.1 and 4.5 μM, human and mouse, respectively). It has minimal effect on TRPV1-4 or TRPM8. AP-18 has been used to study TRPA1 signaling in mice and rats as well as in vitro.

Uses

AP-18 is a selective TRPA1 channel blocker. AP-18 blocks the transient receptor potential ankyrin 1 receptors and can reduce chronic pain associated with arthritis. AP-18 reduces cinnamaldehyde-induced nociception in vivo and blocks cold- and mustard oil-induced activation of mouse TRPA1 but not capsaicin-induced activation. AP-18 reverses CFA-induced mechanical hyperalgesia in mice

Uses

AP-18 is a channel blocker that inhibits TRPA1.

Biological Activity

Reversible TRPA1 channel blocker (IC 50 values are 3.1 and 4.5 μ M at human and mouse TRPA1 respectively). Blocks cinnameldehyde-induced but not capsaicin-induced nociception and reverses mechanical hyperalgesia in vivo . Also blocks TRPA1 pore dilation (IC 50 = 10.3 μM for the inhibition of Yo-Pro uptake).

Biochem/physiol Actions

AP-18 is a selective TRPA1 channel blocker. Transient receptor potential A1 (TRPA1) plays a central role for chemical sensing in the pain pathway. AP-18 is a novel TRPA1 channel blocker. It reduces cinnamaldehyde-induced nociception in vivo and blocks cold- and mustard oil-induced activation of mouse TRPA1 but not capsaicin-induced activation demonstrating selectivity vs. TRPV11. AP-18 reverses CFA-induced mechanical hyperalgesia in mice.

in vivo

ap-18 blocks the transient receptor potential ankyrin 1 receptors and can reduce chronic pain associated with arthritis. this product is also capable to induce cinnamaldehyde-induced nociception and to block cold- and mustard oil-induced activation of mouse trpa1 but not capsaicin-induced activation 2. in addition, ap18 treatment reversed cfa-induced mechanical hyperalgesia in mice 2. thus, trpa1 is essential for sensitization of nociception.

storage

+4°C

References

References”Citations:

4-(4-Chlorophenyl)-3-methylbut-3-en-2-oximeSupplier

J & K SCIENTIFIC LTD.
Tel
010-82848833 400-666-7788
Email
jkinfo@jkchemical.com
3B Pharmachem (Wuhan) International Co.,Ltd.
Tel
821-50328103-801 18930552037
Email
3bsc@sina.com
Shanghai TaoSu Biochemical Technology Co., Ltd.
Tel
021-33632979
Email
info@tsbiochem.com
Sigma-Aldrich
Tel
021-61415566 800-8193336
Email
orderCN@merckgroup.com
EMMX Biotechnology LLC
Tel
888-539-0666
Email
info@emmx.com